Hope for Angioedema Sufferers: Scientists Develop Potential Cure
Angioedema sufferers have long hoped for a cure and scientists may have finally answered their prayers. Researchers from the University of California, San Diego have developed a potential cure for angioedema, a condition which causes sudden and severe swelling of the skin and mucous membranes.
The team of scientists studied a compound called tranilast, which is currently used to treat allergic reactions and asthma. They found that the compound could block the overproduction of certain proteins which cause angioedema. The study, published in the journal Science Translational Medicine, suggests that tranilast could be used as a potential treatment for angioedema.
The researchers tested the drug on mice and found that it reduced the severity of symptoms. They also found that tranilast could block receptors which cause the overproduction of proteins that lead to angioedema.
The scientists concluded that tranilast could be an effective treatment for the condition, which can cause pain, discomfort and even life-threatening swelling. The drug could also be used to prevent angioedema from occurring in the first place, as well as reducing the risk of long-term complications.
The research is still in its early stages, but it offers hope to the millions of people living with angioedema around the world. If further studies are successful, tranilast could be available as a treatment for the condition in the near future. In the meantime, sufferers can take comfort in the knowledge that scientists are working hard to find a cure.